Closed-loop steering locates an evolutionary barrier to multidrug resistance in Escherichia coli
- 1RIKEN
Abstract
Resistance to one drug often raises susceptibility to another; such collateral sensitivity is expected to constrain multidrug resistance. This is hard to test: failure to reach a state is indistinguishable from never having been driven toward it. We therefore recorded the change we imposed: a closed-loop system updated each lineage's drug environment daily based on its measured distance to a target. Steered toward triple chloramphenicol-norfloxacin-kanamycin resistance for 70 days, 52 Escherichia coli lineages gained substantial resistance without converging on the target. The mismatch between imposed and observed movement mapped accessibility, locating a region immediately before the target where progress was reproducibly slowed. Crossing it was associated not with broad resistance mutations shared by most lineages, but with recurrent mutations upstream of the efflux pump gene cmr, which raised chloramphenicol resistance threefold without detectable cost. Progression toward multidrug resistance was therefore constrained without being prevented, at a location consistent with a known physiological trade-off; recording the imposed change makes accessibility measurable during evolution.
Related
- Pathogenome and Plasmid-Borne Antimicrobial Resistance Phenotypes in a Multidrug-Resistant O111:H8 Shiga Toxin-Producing Escherichia coli Strain
- Hybrid sequencing of chromosome and plasmids from multidrug-resistant Escherichia coli isolated in Cambodia: Are megaplasmids vectors of antibiotic resistance genes?
- Multidrug resistance and lipopolysaccharide remodeling associated with mcr-1 acquisition in Shiga toxin-producing Escherichia coli
- Isolation and phenotypic characterization of bacteriophages targeting multidrug-resistant biofilm-forming uropathogenic Escherichia coli from hospital sewage
- Characterisation of multidrug-resistant, avian pathogenic-like Escherichia coli O78 from dairy-bred calves with atypical colisepticaemia
BibTeX
@misc{shibai2026closedloop,
title = {{Closed-loop steering locates an evolutionary barrier to multidrug resistance in Escherichia coli}},
author = {A. Shibai and H. Kotani and C. Furusawa},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.17.752270},
url = {https://www.biorxiv.org/content/10.64898/2026.09.17.752270v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Closed-loop steering locates an evolutionary barrier to multidrug resistance in Escherichia coli
AU - A. Shibai
AU - H. Kotani
AU - C. Furusawa
PY - 2026
DA - 2026/09/17
PB - bioRxiv
DO - 10.64898/2026.09.17.752270
UR - https://www.biorxiv.org/content/10.64898/2026.09.17.752270v1
AB - Resistance to one drug often raises susceptibility to another; such collateral sensitivity is expected to constrain multidrug resistance. This is hard to test: failure to reach a state is indistinguishable from never having been driven toward it. We therefore recorded the change we imposed: a closed-loop system updated each lineage's drug environment daily based on its measured distance to a target. Steered toward triple chloramphenicol-norfloxacin-kanamycin resistance for 70 days, 52 Escherichia coli lineages gained substantial resistance without converging on the target. The mismatch between imposed and observed movement mapped accessibility, locating a region immediately before the target where progress was reproducibly slowed. Crossing it was associated not with broad resistance mutations shared by most lineages, but with recurrent mutations upstream of the efflux pump gene cmr, which raised chloramphenicol resistance threefold without detectable cost. Progression toward multidrug resistance was therefore constrained without being prevented, at a location consistent with a known physiological trade-off; recording the imposed change makes accessibility measurable during evolution.
ER -